Sort
59,101 grants matching “hypertension”
A Novel Magnetic Resonance Imaging Marker of Myocardial Fibrosis
$428,822Michael Jerosch-Herold · Brigham And Women'S Hospital · R01 · FY2011 · HL
The Role of Ets-1 in Vascular Inflammation
$428,822J Peter Oettgen · Beth Israel Deaconess Medical Center · R01 · FY2009 · HL
Renin-Angiotensin and Fibrinolysis Interaction in Humans
$428,771Nancy Joan Brown · Vanderbilt University · R01 · FY2012 · HL
A Novel Magnetic Resonance Imaging Marker of Myocardial Fibrosis
$428,768Michael Jerosch-Herold · Brigham And Women'S Hospital · R01 · FY2010 · HL
Age Associated Changes In Structural And Functional Cardio-Vascular Properties
$428,723Edward Lakatta · National Institute On Aging · ZIA · FY2015 · AG
The role ofglycosaminoglycan N-sulfation in glomerular biology/pathobiology
$428,669Kevin John McCarthy · Louisiana State Univ Hsc Shreveport · R01 · FY2021 · DK
Renal hypoxia in the development of glomerular fibrosis
$428,658Ilknur Ay · Massachusetts General Hospital · R01 · FY2020 · DK
Impact of LifeSkills Training on Blood Pressure in Youth
$428,641Vernon Anthony Barnes · Williams Lifeskills, Inc. · R42 · FY2008 · HL
Genetic and Environment Influences on Expression of CVD Endophenotypes
$428,626Redford B Williams · Duke University · P01 · FY2010 · HL
Pulmonary Vasodilation and Guanylate Cyclase Regulation
$428,625Michael S Wolin · New York Medical College · R01 · FY2008 · HL
ENaC regulation by biliary factors
$428,594Ossama B Kashlan · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · DK
Endothelial dysfunction, nitric oxide and renal failure
$428,587Michael S Goligorsky · New York Medical College · R01 · FY2011 · DK
Examining the Influence of Soc. Determinants of Health on Gestational WeightGain
$428,571Monica L. Baskin · University Of Alabama At Birmingham · U54 · FY2014 · MD
Molecular and Soc. Determinants of Obesity and Metabolic Disorders in Youth
$428,571Melinda S Sothern · University Of Alabama At Birmingham · U54 · FY2014 · MD
Vascular smooth muscle cell phenotypic switching in Pulmonary Hypertension
$428,544Helen Christou · Brigham And Women'S Hospital · R01 · FY2014 · HL
Multipronged approach to diminish sympathetic hyperreflexia and ensuing cardiovascular and immune dysfunction after spinal cord injury
$428,541Veronica Jean Tom · Drexel University · R01 · FY2023 · NS
Multipronged approach to diminish sympathetic hyperreflexia and ensuing cardiovascular and immune dysfunction after spinal cord injury
$428,541Veronica Jean Tom · Drexel University · R01 · FY2025 · NS
Anti-PAH Drugs in Inhalable Nanoparticles for Sustained Pulmonary Vasodilation
$428,533Fakhrul Ahsan · Texas Tech University Health Scis Center · R15 · FY2010 · HL
VASOACTIVE HORMONES AND BLOOD PRESSURE REGULATION
$428,517New York Medical College · R01 · FY2003 · HL
Subcellular Distribution & Regulation of Ala1 Adrenoceptors
$428,516Debra A. Schwinn · University Of Washington · R37 · FY2011 · HL
Multi-Ethnic Study of Atherosclerosis-Eye Study
$428,507University Of Wisconsin Madison · R01 · FY2003 · HL
Treatment of a Complex Retinal Degenerative Syndrome
$428,502Val C Sheffield · University Of Iowa · R01 · FY2014 · EY
Treatment of a Complex Retinal Degenerative Syndrome
$428,500Val C Sheffield · University Of Iowa · R01 · FY2015 · EY
Data Fusion: A Sustainable, Scalable, Open Source Registry Advancing PVD Research
$428,492Steven Herbert Abman · University Of Colorado Denver · U01 · FY2015 · HL
Interleukin-6 and Retinal Ganglion Cell Degeneration in Glaucoma
$428,473Rebecca M Sappington · Wake Forest University Health Sciences · R01 · FY2019 · EY